Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Open-label Investigation to Assess the Pharmacokinetics, Safety and Tolerability of DM199 in Patients With Diabetes Mellitus and Chronic Kidney Disease

NCT03795389 is registered in ClinicalTrials.gov with DiaMedica Therapeutics Inc as lead sponsor.

NCT NCT03795389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03795389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Open-label Investigation to Assess the Pharmacokinetics, Safety and Tolerability of DM199 in Patients With Diabetes Mellitus and Chronic Kidney Disease
Lead sponsor
DiaMedica Therapeutics Inc
Phase
Phase 1
Overall status
Completed
Start date
February 12, 2019
Completion date
July 21, 2019
Enrollment
33 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, chronic kidney disease, stage 3 (moderate), chronic kidney disease, stage 4 (severe), diabetes